Ciprinol

Medicinal product

(Invented) name

Ciprinol

Active substance (s)

Ciprofloksacinas

Strength

100 mg/10 ml

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01MA02, Ciprofloxacin

Marketing authorisation holder

UAB Rx pharma, Lietuva

Date of authorisation

2025-01-28

Date of renewal

Documents

2344_Ciprinol 10mg-ml konc_inf_tirp_PZ_2025-01-28.docx

2344_Ciprinol 10mg-ml konc_inf_tirp_PL_2025-01-28.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

10 ml koncentrato yra	10 ml
Ciprofloksacinas	100 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
116446	102546	1102546	ampulė	10 ml N5	ASPĮ	Receptinis	LT/L/25/2344/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2025-01-28	Registruotas